most interesting articles

News Center

2018-07-03

Melanotan sustained release products

Australian EpiTan company has applied for new international patents for all the sustained-release dosage forms of its leading product Melanotan, The patent application covers a variety of existing sustained-release dosage forms, including subcutaneous imp